	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	September 29, 2013		September 23, 2012		September 29, 2013		September 23, 2012
		(In thousands)
JBS USA:
Subordinated loan interest^(a)	$	-	$	-	$	-	$	971
Letter of credit fees^(b)		513		592		1,697		1,776
JBS USA, LLC:
Purchases from JBS USA, LLC^(c)		19,155		18,136		59,945		49,847
Expenditures paid by JBS USA, LLC on behalf of Pilgrim's Pride Corporation^(d)		11,281		14,469		34,659		44,194
Sales to JBS USA, LLC^(c)		13,996		58,527		49,263		177,894
Expenditures paid by Pilgrim's Pride Corporation on behalf of JBS USA, LLC^(d)		630		1,089		1,313		3,645
Former Founder Director:
Consulting fee paid to former Founder Director^(e)		-		-		-		374
Board fees paid to former Founder Director^(e)		-		-		-		45
Contract grower compensation paid to former Founder Director ^(f)		-		-		-		297
Sales to former Founder Director		-		-		-		1


(a)		On June 23, 2011, we executed a subordinated loan agreement with JBS USA that provided an aggregate loan commitment of $100.0 million and immediately borrowed $50.0 million under the resulting facility at an interest rate of 9.845% per annum. On March 7, 2012, we repaid the outstanding $50.0 million loan, along with $3.5 million accrued interest, and terminated the loan commitment under the agreement.
(b)		Beginning on October 26, 2011, JBS USA arranged for letters of credit to be issued on its account in the amount of $56.5 million to an insurance company on our behalf in order to allow that insurance company to return cash it held as collateral against potential liability claims. We agreed to reimburse JBS USA up to $56.5 million for potential draws upon these letters of credit. We reimburse JBS USA for the letter of credit costs we would have otherwise incurred under our credit facilities. During the thirteen and thirty-nine weeks ended September 29, 2013, we have paid JBS USA $0.6 million and $1.8 million, respectively, for letter of credit costs. As of September 29, 2013, the Company has accrued an obligation of $0.1 million to reimburse JBS USA for letter of credit costs incurred on its behalf.
(c)		We routinely execute transactions to both purchase products from JBS USA, LLC and sell products to them. As of September 29, 2013 and December 30, 2012, the outstanding payable to JBS USA, LLC was $5.9 million and $13.4 million, respectively. As of September 29, 2013 and December 30, 2012, the outstanding receivable from JBS USA, LLC was $4.5 million and $1.5 million, respectively. As of September 29, 2013, approximately $0.8 million of goods from JBS USA, LLC were in transit and not reflected on our Condensed Consolidated Balance Sheet.
(d)		On January 19, 2010, we executed an agreement with JBS USA, LLC in order to allocate costs associated with the procurement of SAP licenses and maintenance services by JBS USA, LLC for the combined companies. Under this agreement, the fees associated with procuring SAP licenses and maintenance services are allocated between us and JBS USA, LLC in proportion to the percentage of licenses used by each company. The agreement expires on the date of expiration, or earlier termination, of each underlying SAP license agreement. During 2013, we have paid JBS USA $1.0 million for the procurement of such licenses and services. On May 5, 2010, we executed an agreement with JBS USA, LLC in order to allocate the costs of supporting the business operations through one consolidated corporate team. Expenditures paid by JBS USA, LLC on our behalf are reimbursed by us and expenditures paid by us on behalf of JBS USA, LLC are reimbursed by JBS USA, LLC. This agreement expires on May 5, 2015. During 2013, we have paid JBS USA, LLC $33.3 million for net expenditures paid by JBS USA, LLC on our behalf. At September 29, 2013, the outstanding net payable to JBS USA resulting from affiliate trade, procurement of SAP licenses and maintenance services and support of the business operations through one consolidated corporate team was $4.5 million.
(e)		On December 28, 2009, we executed a consulting agreement with the former Founder Director. The terms of the agreement on that date included, among other things, that the former Founder Director (i) will provide services to us that are comparable in the aggregate with the services provided by him to us prior to December 28, 2009, (ii) will be appointed to our Board of Directors and, during the term of the agreement, will be nominated for subsequent terms on the Board, (iii) will be compensated for services rendered to us at a rate of $1.5 million per annum for a term of five years, (iv) will be subject to customary non-solicitation and non-competition provisions and (v) will be, along with his spouse, provided with medical benefits (or will be compensated for medical coverage) that are comparable in the aggregate to the medical benefits afforded to our employees. As a result of his resignation as Founder Director, we are no longer required to nominate the Founder Director to serve subsequent terms on the Board. During the period in 2012 in which the former Founder Director was a related party, we paid $0.4 million to him under this agreement.
(f)		We have executed various grower contracts with the former Founder Director that provide for the placement of our flocks on farms owned by the former Founder Director during the grow-out phase of production. These contracts include terms that are substantially identical to those included in contracts executed by us with unaffiliated parties. The former Founder Director can terminate the contracts upon completion of the grow-out phase for each flock. We can terminate the contracts within a specified period of time pursuant to regulations by the Grain Inspection, Packers and Stockyards Administration of the U.S. Department of Agriculture. During the period in 2012 in which the former Founder Director was a related party, we paid $0.3 million to him under these contracts.